Literature DB >> 27780544

Isolation of human trophoblastic extracellular vesicles and characterization of their cargo and antiviral activity.

Yingshi Ouyang1, Avraham Bayer1, Tianjiao Chu1, Vladimir A Tyurin2, Valerian E Kagan2, Adrian E Morelli3, Carolyn B Coyne4, Yoel Sadovsky5.   

Abstract

INTRODUCTION: Primary human trophoblasts release a repertoire of extracellular vesicles (EVs). Among them are nano-sized exosomes, which we found to suppress the replication of a wide range of diverse viruses. These exosomes contain trophoblastic microRNAs (miRNAs) that are expressed from the chromosome 19 miRNA cluster and exhibit antiviral properties. Here, we report our investigation of the cargo of placental EVs, focusing on the composition and the antiviral properties of exosomes, microvesicles, and apoptotic blebs.
METHODS: We isolated EVs using ultracentrifugation and defined their purity using immunoblotting, electron microscopy, and nanoparticle tracking. We used liquid chromatography-electrospray ionization-mass spectrometry, protein mass spectrometry, and miRNA TaqMan card PCR to examine the phospholipids, proteins, and miRNA cargo of trophoblastic EVs and an in vitro viral infection assay to assess the antiviral properties of EVs.
RESULTS: We found that all three EV types contain a comparable repertoire of miRNA. Interestingly, trophoblastic exosomes harbor a protein and phospholipid profile that is distinct from that of microvesicles or apoptotic blebs. Functionally, trophoblastic exosomes exhibit the highest antiviral activity among the EVs. Consistently, plasma exosomes derived from pregnant women recapitulate the antiviral effect of trophoblastic exosomes derived from in vitro cultures of primary human trophoblasts. DISCUSSION: When compared to other trophoblastic EVs, exosomes exhibit a unique repertoire of proteins and phospholipids, but not miRNAs, and a potent viral activity. Our work suggests that human trophoblastic EVs may play a key role in maternal-placental-fetal communication.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C19MC; Exosomes; Placenta; Plasma exosomes; Trophoblastic vesicles; Viral infection

Mesh:

Substances:

Year:  2016        PMID: 27780544      PMCID: PMC5123854          DOI: 10.1016/j.placenta.2016.09.008

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  87 in total

Review 1.  Placental extracellular vesicles and feto-maternal communication.

Authors:  M Tong; L W Chamley
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

2.  The endogenous retroviral envelope protein syncytin-1 inhibits LPS/PHA-stimulated cytokine responses in human blood and is sorted into placental exosomes.

Authors:  J M Tolosa; J E Schjenken; V L Clifton; A Vargas; B Barbeau; P Lowry; K Maiti; R Smith
Journal:  Placenta       Date:  2012-09-20       Impact factor: 3.481

3.  The expression of Argonaute2 and related microRNA biogenesis proteins in normal and hypoxic trophoblasts.

Authors:  Rogier B Donker; Jean-François Mouillet; D Michael Nelson; Yoel Sadovsky
Journal:  Mol Hum Reprod       Date:  2007-02-27       Impact factor: 4.025

4.  Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants.

Authors:  Réjean Cantin; Juliette Diou; Dave Bélanger; Alexandre M Tremblay; Caroline Gilbert
Journal:  J Immunol Methods       Date:  2008-07-31       Impact factor: 2.303

5.  Placenta-derived exosomes and syncytiotrophoblast microparticles and their role in human reproduction: immune modulation for pregnancy success.

Authors:  Lucia Mincheva-Nilsson; Vladimir Baranov
Journal:  Am J Reprod Immunol       Date:  2014-08-28       Impact factor: 3.886

6.  Purification of human plasma fibronectin using immobilized gelatin and Arg affinity chromatography.

Authors:  Pietro Speziale; Livia Visai; Simonetta Rindi; Antonella Di Poto
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

7.  Proteomic characterization of macro-, micro- and nano-extracellular vesicles derived from the same first trimester placenta: relevance for feto-maternal communication.

Authors:  Mancy Tong; Torsten Kleffmann; Shantanu Pradhan; Caroline L Johansson; Joana DeSousa; Peter R Stone; Joanna L James; Qi Chen; Larry W Chamley
Journal:  Hum Reprod       Date:  2016-02-01       Impact factor: 6.918

8.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

9.  Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity.

Authors:  Chris Gardiner; Dionne S Tannetta; Carol A Simms; Paul Harrison; Christopher W G Redman; Ian L Sargent
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

10.  Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers.

Authors:  Verena Köberle; Thomas Pleli; Christian Schmithals; Eduardo Augusto Alonso; Jörg Haupenthal; Halvard Bönig; Jan Peveling-Oberhag; Ricardo M Biondi; Stefan Zeuzem; Bernd Kronenberger; Oliver Waidmann; Albrecht Piiper
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

View more
  41 in total

1.  Unique microRNA Signals in Plasma Exosomes from Pregnancies Complicated by Preeclampsia.

Authors:  Hui Li; Yingshi Ouyang; Elena Sadovsky; W Tony Parks; Tianjiao Chu; Yoel Sadovsky
Journal:  Hypertension       Date:  2020-01-27       Impact factor: 10.190

2.  Chromosome 19 microRNAs exert antiviral activity independent from type III interferon signaling.

Authors:  Avraham Bayer; Nicholas J Lennemann; Yingshi Ouyang; Elena Sadovsky; Megan A Sheridan; R Michael Roberts; Carolyn B Coyne; Yoel Sadovsky
Journal:  Placenta       Date:  2017-11-10       Impact factor: 3.481

Review 3.  Placental small extracellular vesicles: Current questions and investigative opportunities.

Authors:  Yoel Sadovsky; Yingshi Ouyang; Juliana S Powell; Hui Li; Jean-Francois Mouillet; Adrian E Morelli; Alexander Sorkin; Leonid Margolis
Journal:  Placenta       Date:  2020-03-10       Impact factor: 3.481

4.  Isolation of exosomes from whole blood by integrating acoustics and microfluidics.

Authors:  Mengxi Wu; Yingshi Ouyang; Zeyu Wang; Rui Zhang; Po-Hsun Huang; Chuyi Chen; Hui Li; Peng Li; David Quinn; Ming Dao; Subra Suresh; Yoel Sadovsky; Tony Jun Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

Review 5.  Extracellular vesicles and their immunomodulatory functions in pregnancy.

Authors:  Soumyalekshmi Nair; Carlos Salomon
Journal:  Semin Immunopathol       Date:  2018-04-03       Impact factor: 9.623

6.  Organotypic models of type III interferon-mediated protection from Zika virus infections at the maternal-fetal interface.

Authors:  Jacqueline Corry; Nitin Arora; Charles A Good; Yoel Sadovsky; Carolyn B Coyne
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

Review 7.  Microbial Vertical Transmission during Human Pregnancy.

Authors:  Nitin Arora; Yoel Sadovsky; Terence S Dermody; Carolyn B Coyne
Journal:  Cell Host Microbe       Date:  2017-05-10       Impact factor: 21.023

8.  The expression level of C19MC miRNAs in early pregnancy and in response to viral infection.

Authors:  Tina M F Dumont; Jean-Francois Mouillet; Avaraham Bayer; Christina L Gardner; William B Klimstra; Dana G Wolf; Simcha Yagel; Fabiola Balmir; Anna Binstock; Joseph S Sanfilippo; Carolyn B Coyne; Jacob C Larkin; Yoel Sadovsky
Journal:  Placenta       Date:  2017-03-16       Impact factor: 3.481

Review 9.  Trophoblastic extracellular vesicles and viruses: Friends or foes?

Authors:  Yingshi Ouyang; Jean-Francois Mouillet; Alexander Sorkin; Yoel Sadovsky
Journal:  Am J Reprod Immunol       Date:  2020-09-27       Impact factor: 3.886

Review 10.  Placental extracellular vesicles and pre-eclampsia.

Authors:  Jessica Schuster; Shi-Bin Cheng; James Padbury; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2020-07-18       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.